Abstract
The symptoms of Parkinson’s disease (PD) commonly include a number of sleep disorders, including restless legs syndrome (RLS) and periodic limb movements of sleep (PLMS). RLS occurs in about 20 % of PD patients in most studies, but idiopathic RLS does not seem to precede the development of PD. In fact there is some evidence that idiopathic RLS may prevent the subsequent development of PD. In cases of PD/RLS the PD usually presents first, and RLS may represent one of many non-motor features associated with PD. Although common, RLS is usually not a major contributor to sleep deprivation or functional impairment in the PD population. PLMS are seen in many neurodegenerative disorders, as well as idiopathic RLS. Most studies report higher rates of PLMS in PD, but polysomnography studies suggest relatively little impact of PLMS on other sleep measures. The response of both PD and RLS to dopaminergics is of great interest, especially given the lack of overt dopamine pathology in RLS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wetter TC, et al. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep. 2000;23(3):361–7.
Horiguchi J, et al. [Sleep-wake complaints in Parkinson’s disease]. Rinsho Shinkeigaku Clin Neurol. 1990;30(2):214–6.
Banno K, et al. Restless legs syndrome in 218 patients: associated disorders. Sleep Med. 2000;1(3):221–9.
Lang AE. Restless legs syndrome and Parkinson’s disease: insights into pathophysiology. Clin Neuropharmacol. 1987;10(5):476–8.
Paulson G. Is restless legs a prodrome to Parkinson’s disease. Mov Disord. 1997;12 Suppl 1:68.
Allen RP, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–19.
Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology. 1996;47(6):1435–41.
Hening W, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5(3):237–46.
Tan EK, et al. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord. 2001;16(3):577–9.
Winkelmann J, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000–6.
Stefansson H, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007;357(7):639–47.
Chen S, et al. Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet. 2004;74(5):876–85.
Desautels A, et al. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. [see comment]. Am J Hum Genet. 2001;69(6):1266–70.
Bonati MT, et al. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain. 2003;126(Pt 6):1485–92.
Earley CJ, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54(8):1698–700.
Schmidauer C, et al. Brain parenchyma sonography differentiates RLS patients from normal controls and patients with Parkinson’s disease. Mov Disord. 2005;20 Suppl 10:S43.
Allen RP, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56(2):263–5.
Connor JR, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology. 2004;62(9):1563–7.
Connor JR, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61(3):304–9.
Ryu JH, Lee MS, Baik JS. Sonographic abnormalities in idiopathic restless legs syndrome (RLS) and RLS in Parkinson’s disease. Parkinsonism Relat Disord. 2010;17(3):201–3.
Kwon DY, et al. Transcranial brain sonography in Parkinson’s disease with restless legs syndrome. Mov Disord. 2010;25(10):1373–8.
Garcia-Borreguero D, et al. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep. 2004;27(4):669–73.
Trenkwalder C, et al. Positron emission tomographic studies in restless legs syndrome. Mov Disord. 1999;14(1):141–5.
Ruottinen HM, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology. 2000;54(2):502–4.
Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology. 1999;52(5):932–7.
Michaud M, et al. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol. 2002;249(2):164–70.
Linke R, et al. Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson’s disease? Mov Disord. 2004;19(10):1158–62.
Eisensehr I, et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology. 2001;57(7):1307–9.
Earley CJ, et al. The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep. 2011;34(3):341–7.
Qu S, et al. Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome. J Neuropathol Exp Neurol. 2007;66(5):383–8.
Stiasny-Kolster K, et al. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. Mov Disord. 2004;19(2):192–6.
Earley CJ, Hyland K, Allen RP. CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome. Mov Disord. 2001;16(1):144–9.
Earley CJ, Hyland K, Allen RP. Circadian changes in CSF dopaminergic measures in restless legs syndrome. Sleep Med. 2006;7(3):263–8.
Pittock SJ, et al. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord. 2004;19(6):695–9.
Ye Z, Connor JR. Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions. Nucleic Acids Res. 2000;28(8):1802–7.
Wang X, et al. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome. J Neurol Sci. 2004;220(1–2):59–66.
Jeng CJ, et al. Thy-1 is a component common to multiple populations of synaptic vesicles. J Cell Biol. 1998;140(3):685–98.
Vilarino-Guell C, et al. Susceptibility genes for restless legs syndrome are not associated with Parkinson disease. Neurology. 2008;71(3):222–3.
Adel S, et al. Co-occurrence of restless legs syndrome and Parkin mutations in two families. Mov Disord. 2006;21(2):258–63.
Pichler I, et al. Parkin gene modifies the effect of RLS4 on the age at onset of restless legs syndrome (RLS). Am J Med Genet B Neuropsychiatr Genet. 2010;153B(1):350–5.
Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol. 2002;59(3):421–4.
Driver-Dunckley E, et al. Restless legs syndrome in Parkinson’s disease patients may improve with subthalamic stimulation. Mov Disord. 2006;21(8):1287–9.
Peralta CM, et al. Restless legs syndrome in Parkinson’s disease. Mov Disord. 2009;24:2076–80.
Simuni T, Wilson R, Stern MB. Prevalence of restless legs syndrome in Parkinson’s disease. Mov Disord. 2000;15(Supple 5):1043.
Braga-Neto P, et al. Snoring and excessive daytime sleepiness in Parkinson’s disease [erratum appears in J Neurol Sci. 2004;219(1–2):171]. J Neurol Sci. 2004;217(1):41–5.
Chaudhuri KR, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21(7):916–23.
Verbaan D, et al. Prevalence and clinical profile of restless legs syndrome in Parkinson’s disease. Mov Disord. 2010;25(13):2142–7.
Loo HV, Tan EK. Case-control study of restless legs syndrome and quality of sleep in Parkinson’s disease. J Neurol Sci. 2008;266(1–2):145–9.
Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson’s disease. Mov Disord. 2002;17(4):775–81.
Krishnan PR, Bhatia M, Behari M. Restless legs syndrome in Parkinson’s disease: a case-controlled study. Mov Disord. 2003;18(2):181–5.
Nomura T, et al. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson’s disease. Mov Disord. 2006;21(3):380–4.
Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson’s disease. J Neurol Sci. 2002;196(1–2):33–6.
Rijsman RM, et al. Restless legs syndrome in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20 Suppl 1:S5–9.
Gjerstad MD, Tysnes OB, Larsen JP. Increased risk of leg motor restlessness but not RLS in early Parkinson disease. Neurology. 2011;77(22):1941–6.
Fazzini E, Diaz R, Fahn S. Restless legs in Parkinson’s disease-clinical evidence for underactivity of catecholamine neurotransmission. [abstract]. Ann Neurol. 1989;26:142.
Walters AS, et al. A preliminary look at the percentage of patients with Restless Legs Syndrome who also have Parkinson Disease, Essential Tremor or Tourette Syndrome in a single practice. J Sleep Res. 2003;12(4):343–5.
Gao X, et al. Restless legs syndrome and Parkinson’s disease in men. Mov Disord. 2010;25(15):2654–7.
Wong JC, et al. Restless legs syndrome: an early clinical feature of Parkinson disease in men. Sleep. 2014;37(2):369–72.
Ancoli-Israel S, et al. Periodic limb movements in sleep in community-dwelling elderly. Sleep. 1991;14(6):496–500.
Mosko SS, et al. Sleep apnea and sleep-related periodic leg movements in community resident seniors. J Am Geriatr Soc. 1988;36(6):502–8.
Bara-Jimenez W, et al. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. [comment]. Neurology. 2000;54(8):1609–16.
Pennestri MH, et al. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology. 2007;68(15):1213–8.
Walters AS, Rye DB. Evidence continues to mount on the relationship of restless legs syndrome/periodic limb movements in sleep to hypertension, cardiovascular disease, and stroke. Sleep. 2010;33(3):287.
Winkelman JW, et al. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology. 2008;70(1):35–42.
Montplaisir J, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61–5.
Coleman RM, et al. Sleep-wake disorders in the elderly: polysomnographic analysis. J Am Geriatr Soc. 1981;29(7):289–96.
Trenkwalder C. Sleep dysfunction in Parkinson’s disease. Clin Neurosci. 1998;5(2):107–14.
Covassin N, et al. Clinical correlates of periodic limb movements in sleep in Parkinson’s disease. J Neurol Sci. 2012;316(1–2):131–6.
Wetter TC, et al. Polysomnographic measures in Parkinson’s disease: a comparison between patients with and without REM sleep disturbances. Wien Klin Wochenschr. 2001;113(7–8):249–53.
Ma JF, et al. Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial. Sleep Med. 2012;13(1):58–63.
Happe S, et al. Periodic leg movements in patients with Parkinson’s disease are associated with reduced striatal dopamine transporter binding. J Neurol. 2003;250(1):83–6.
Hogl B, et al. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson’s disease. Neuropsychopharmacology. 2003;28(10):1866–70.
Shpirer I, et al. Excessive daytime sleepiness in patients with Parkinson’s disease: a polysomnography study. Mov Disord. 2006;21(9):1432–8.
Rye DB, DeLong MR. Amelioration of sensory limb discomfort of restless legs syndrome by pallidotomy. Ann Neurol. 1999;46(5):800–1.
Chahine LM, Ahmed A, Sun Z. Effects of STN DBS for Parkinson’s disease on restless legs syndrome and other sleep-related measures. Parkinsonism Relat Disord. 2011;17(3):208–11.
Kedia S, et al. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology. 2004;63(12):2410–2.
Parra J, et al. [Severe restless legs syndrome following bilateral subthalamic stimulation to treat a patient with Parkinson’s disease]. Rev Neurol. 2006;42(12):766–7.
Ondo WG, et al. Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome. Sleep Med. 2012;13(9):1202–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Wien
About this chapter
Cite this chapter
Ondo, W.G. (2015). Restless Legs Syndrome and Periodic Limb Movements in Parkinson’s Disease. In: Videnovic, A., Högl, B. (eds) Disorders of Sleep and Circadian Rhythms in Parkinson's Disease. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1631-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1631-9_12
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1630-2
Online ISBN: 978-3-7091-1631-9
eBook Packages: MedicineMedicine (R0)